Sen. Ron Wyden (D-Ore.), who is helping to negotiate the health care spending framework for the Democrats' budget plan, said lawmakers may have to settle for very basic versions of programs deployed in the package. But the key, he added, is to get the "architecture of these changes, bold changes," started and show people what is possible.
WASHINGTON (AP) — Lawmakers’ most consequential battle this year over President Joe Biden’s expansive domestic agenda will snake through a legislative maze that's eye-rolling even by Congress’ standards.
WASHINGTON (AP) — Senate Majority Leader Chuck Schumer pressured lawmakers Thursday to reach agreement by next week on a pair of massive domestic spending measures, signaling Democrats’ desire to push ahead aggressively on President Joe Biden’s multitrillion-dollar agenda.
Democrats in Congress reached a tentative agreement to press ahead on a partisan bill that would dramatically expand health benefits for people on Medicare, those who buy their own insurance and individuals who have been shut out of coverage in states that didn’t expand Medicaid. Meanwhile, controversy continues to rage over whether vaccinated Americans will need a booster to protect against covid-19 variants, and who will pay for a new drug to treat Alzheimer’s disease. Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Rae Ellen Bichell, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a mother and daughter who fought an enormous emergency room bill.
The plan from high-wire negotiations would affect five key areas of health, but there will be further tense negotiations among Democratic lawmakers about specifics of the $3.5 trillion in funding. And all Senate Democrats will need to be behind the plan, because Republicans oppose it.
WASHINGTON (AP) — President Joe Biden made a quick foray to the Capitol on Wednesday hunting support for his multitrillion-dollar agenda of infrastructure, health care and other programs, a potential landmark achievement that would require near-unanimous backing from fractious Democrats.
WASHINGTON (AP) — With COVID-19 on the rise again and many nursing home staffers unvaccinated, families still lack easy access to crucial Medicare immunization data that will help them pick the right facility for their loved one.
Health and Human Services Secretary Xavier Becerra is the special guest for this bonus episode of KHN’s “What the Health?” podcast. He and host Julie Rovner discuss a breadth of topics the secretary oversees, including covid-19, prescription drug prices, Medicare, Medicaid and the Affordable Care Act.
In an interview for KHN’s “What the Health?” podcast, HHS Secretary Xavier Becerra says the administration is eager for Congress to make changes to Medicare that will provide more benefits and make more older adults eligible for the program. He also said a priority will be making permanent the enhanced premium subsidies for Affordable Care Act marketplace plans.
WASHINGTON (AP) — Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and unproven benefits have prompted widespread criticism and a congressional investigation.
ATLANTA (AP) — The Biden administration's decision to reevaluate Georgia's plan to overhaul how state residents buy health insurance under the Affordable Care Act came as a “surprise” and suggests it wants to revisit the plan's approval, which is not allowed, Gov. Brian Kemp's office said.
WASHINGTON (AP) — A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use.
FRANKFORT, Ky (AP) — State Rep. Attica Scott, one of two Black women in Kentucky's legislature, announced Wednesday that she'll try to unseat longtime Democratic Congressman John Yarmuth in the state’s only congressional district controlled by Democrats.
The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act, in an effort to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive new drug that might or might not slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of The Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
LANSING, Mich. (AP) — Rehabilitation facilities and in-home providers who help people catastrophically injured in car crashes could apply for $25 million in state aid under legislation that was advanced to Gov. Gretchen Whitmer on Wednesday, two days before rate cuts take effect.
In the weeks since a new Alzheimer's drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment that has sparked both excitement and skepticism.
WASHINGTON (AP) — Many working-age people assume that Medicare covers just about every kind of health care that an older person may need.
Democrats in Congress and the states are devising strategies to expand health coverage — through the Affordable Care Act, Medicare, Medicaid and a “public option.” But progress remains halting, at best. Meanwhile, lawmakers in Washington may have to agree on how to control prescription drug prices if they wish to finance their coverage initiatives. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Michelle Andrews, who reported and wrote last month’s KHN-NPR “Bill of the Month” episode about a very expensive sleep study.
In a surprisingly strong 7-2 decision, the Supreme Court turned back the latest constitutional challenge to the Affordable Care Act, likely heralding the end of GOP efforts to strike the law in its entirety through court action. Meanwhile, Democratic lawmakers are looking for ways to expand health benefits. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Andy Slavitt, who recently stepped down from the Biden administration’s covid response team, about his new book on the pandemic.
A new Alzheimer's drug would raise Medicare premiums broadly, and some patients could face copayments of about $11,500 annually, a report says.
Chiquita Brooks-LaSure, the new head of the Centers for Medicare & Medicaid Services, said the administration will focus on getting more people insured and is interested in finding a way to alleviate the gap keeping low-income families in states that haven’t expanded Medicaid from enrolling in Affordable Care Act health plans.